A Kinsey Institute survey of 2,000 adults found that among GLP-1 users, 18% reported increased sexual desire and 16% reported decreased desire effects running almost equally in both directions [2]
The Verdict: A novel ingredient with intriguing mechanisms, but human clinical data is needed to confirm safety and effectiveness
Le Thanh-Blicharz, J., Aniola, J., Kowalczewski, P., Przygonski, K., Zaborowska, Z., & Lewandowicz, G
Clinical considerations for delayed dosing include the potential for breakthrough hyperglycemia in patients with diabetes and increased appetite in those using semaglutide for weight management
Duration of each program will vary and is based on frequency of the personalized dosing schedule